CLINICAL_TRIALS
trial_result
· 2014-11-21
Clinical Trial Update: A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 study comparing Naltrexone SR/Bupropion SR to placebo in obese adults with Type 2 diabetes completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Orexigen Therapeutics, Inc | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2014-11-21